Lupin Pharmaceuticals Inc. 2024-06-26 Health serious FDA
Health · FDA · Recall #FDA-D-0559-2024
Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral… Recall
Issued June 26, 2024 · Lupin Pharmaceuticals Inc.
In June 2024, Lupin Pharmaceuticals Inc. recalled the Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Content Uniformity Specifications
What you should do
- 1 Stop using Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Lupin Pharmaceuticals Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Lupin Pharmaceuticals Inc.
- Category
- Health
- Recall date
- June 26, 2024
- Units affected
- Not reported
- Sold at
- Nationwide in the US
- Recall number
- FDA-D-0559-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- Lupin Pharmaceuticals Inc. has 19 recalls in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.